NCT07146412 · RECRUITING

Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study

This trial is testing a multimodal lifestyle intervention — combining multiple lifestyle changes at once — to see whether it can reduce dementia risk factors in cognitively healthy older adults who have a family history of dementia. Researchers also want to understand how people feel about learning their personal risk. This is a Phase NA pilot study, meaning it is a small early-stage logistical test to work out the methods before a larger trial.

You may qualify if

  • Adults 65-75 years of age at enrollment with at least one self-reported 1st-degree relative who had or has any kind of dementia
  • Montreal Cognitive Assessment (MoCA) score > 24 at initial enrollment
  • Able and willing to comprehend and sign the informed consent document
  • Able and willing to perform required physical performance tests
  • Able and willing to provide the study's minimum samples
  • Able and willing to conduct the study's minimum procedures
  • Able and willing to complete surveys, cognitive assessments, and questionnaires in English only
  • Has or has ready access to a PC, tablet, or smartphone with an internet connection required for procedures that they consent to

You're excluded if

  • A diagnosis of cognitive impairment of any kind, including Alzheimer's disease, mild cognitive impairment, or any other diagnosis of dementia
  • If a subject is found to have cognitive impairment at initial enrollment (Montreal Cognitive Assessment (MoCA) score\<25), they will be excluded from the study
  • Self-reported pregnancy
  • Children under 19 years of age
  • Individuals not fluent in written and spoken English
  • Self-reported chronic or end-stage disease that would interfere with their participation in the study
  • Hospitalization for any reason in the past 3 months
  • Severe hearing and visual impairment that would interfere with the ability to complete study measures
  • Any other vulnerable subject at the time of enrollment as specified above

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-08-28

View full record on ClinicalTrials.gov

All APOE4 clinical trials